DePuy Synthes is a medical technology company that focuses on innovations in orthopaedic surgery, support, and education for providers. It is part of the Johnson & Johnson MedTech group.

DePuy Synthes

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Conformis, Inc.

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Enovis Corporation

TBF is specialized in tissue engineering, offering a comprehensive range of bone substitutes for clinical needs in implantology and maxillofacial surgery. The company provides human-derived bone grafts that are treated for safety and effectiveness.

Metric
Company Name	DePuy Synthes	Conformis, Inc.	Enovis Corporation	TBF
Symbol		CFMS	ENOV
MSH ID	COM:DEPUYSYNTHES	COM:CONFORMIS	COM:ENOVIS	COM:TBF-LAB
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Industrials	Healthcare & Health Services
Industry	Medical Technology	Medical - Devices	Industrial - Machinery	Medical Devices
Country	US	US	US	FR
Stage
Employee Count		295	6.55K
Website	depuysynthes.com	conformis.com	enovis.com	tbf-lab.com
LinkedIn
Founders

Metric
Market Cap	17.88M	2.40B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	62.05M	1.71B
Revenue (LTM)
Revenue (NTM)
Gross Profit	23.21M	990.78M
EBITDA	-46.23M	194.39M
Operating Income	-46.28M	-65.71M
Net Income	-50.47M	-33.26M
EPS	-6.99	-0.61
Diluted EPS	-6.99	-0.61
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.33	0.58
Operating Profit Margin	-0.71	-0.04
EBITDA Margin	-0.74	0.11
Net Profit Margin	-0.73	-0.02
Return on Equity	-0.86	-0.01
Return on Assets	-0.61	-0.01
Return on Capital Employed	-0.71	-0.02

COM:DEPUYSYNTHES

DePuy Synthes

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.40	-35.50
P/B Ratio	0.52	0.93
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.31	1.92
EV Multiple	-0.45	50.02

Metric
Days Sales Outstanding	49.87	60.88
Days Payables Outstanding	34.32	64.95
Days Inventory Outstanding	182.18	280.07
Operating Cycle	232.05	356.60
Cash Conversion Cycle	197.73	282.17
Asset Turnover	0.84	0.38

Metric
Operating Cash Flow	-50.15M	134.99M
Free Cash Flow	-52.07M	12.77M
Cash Flow to Debt	-1.67	0.25
Operating Cash Flow/Sales	-0.78	0.08
Free Cash Flow Yield	-2.61	-0.03

Metric
Cash & Equivalents	48.67M	36.19M
Accounts Receivable	-945K	-16.32M
Inventory	18.91M	468.83M
Goodwill		2.06B
Debt to Capitalization	0.45	0.30
Debt to Assets	0.39	0.11
Current Ratio	5.07	2.40
Quick Ratio	3.15	1.08

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.03	0.02
R&D to Revenue	0.20	0.04
SG&A to Revenue	0.47